Cathay Biotech is forecast to grow earnings and revenue by 17% and 10.7% per annum respectively. EPS is expected to grow by 16.8% per annum. Return on equity is forecast to be 5.1% in 3 years.
Key information
17.0%
Earnings growth rate
16.81%
EPS growth rate
Chemicals earnings growth
29.3%
Revenue growth rate
10.7%
Future return on equity
5.15%
Analyst coverage
Low
Last updated
19 May 2026
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
XSSC:688065 - Analysts future estimates and past financials data (CNY Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2028
4,509
1,016
N/A
1,470
1
12/31/2027
4,052
943
N/A
744
1
12/31/2026
3,568
848
N/A
1,136
1
3/31/2026
3,394
589
-463
296
N/A
12/31/2025
3,295
561
-339
404
N/A
9/30/2025
3,288
594
-327
418
N/A
6/30/2025
3,184
550
88
725
N/A
3/31/2025
3,049
521
33
693
N/A
12/31/2024
2,958
489
-22
821
N/A
9/30/2024
2,764
398
-157
715
N/A
6/30/2024
2,528
372
-686
681
N/A
3/31/2024
2,293
414
-840
705
N/A
12/31/2023
2,114
367
-1,000
569
N/A
9/30/2023
2,169
381
-1,515
685
N/A
6/30/2023
2,183
459
-2,031
766
N/A
3/31/2023
2,285
436
-2,889
738
N/A
12/31/2022
2,441
553
-3,395
804
N/A
9/30/2022
2,447
605
-3,399
794
N/A
6/30/2022
2,517
619
-2,748
601
N/A
3/31/2022
2,538
628
-1,848
610
N/A
12/31/2021
2,363
595
-880
579
N/A
9/30/2021
2,099
612
-409
684
N/A
6/30/2021
1,839
564
-231
637
N/A
3/31/2021
1,579
481
-48
659
N/A
12/31/2020
1,497
458
-248
515
N/A
9/30/2020
1,482
428
-139
201
N/A
6/30/2020
1,601
432
-70
403
N/A
3/31/2020
1,722
475
-337
290
N/A
12/31/2019
1,916
479
N/A
360
N/A
12/31/2018
1,757
466
N/A
-10
N/A
12/31/2017
1,363
333
N/A
53
N/A
12/31/2016
929
145
N/A
-129
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688065's forecast earnings growth (17% per year) is above the savings rate (2.4%).
Earnings vs Market: 688065's earnings (17% per year) are forecast to grow slower than the CN market (27.5% per year).
High Growth Earnings: 688065's earnings are forecast to grow, but not significantly.
Revenue vs Market: 688065's revenue (10.7% per year) is forecast to grow slower than the CN market (16.8% per year).
High Growth Revenue: 688065's revenue (10.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688065's Return on Equity is forecast to be low in 3 years time (5.1%).
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/06 10:47
End of Day Share Price
2026/07/06 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cathay Biotech Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.